2.1 Osteoporosis: Definitions, Types, and WHO Diagnostic Criteria

2.1 Osteoporosis: Definitions, Types, and WHO Diagnostic Criteria

Quick Answer: Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Bone strength integrates bone mineral density (BMD), which accounts for roughly 60% to 70% of skeletal breaking strength in mechanical testing, and bone quality, which accounts for the remainder. The World Health Organization (WHO) classifies central DXA T-scores as Normal ($T \ge -1.0$), Low Bone Mass / Osteopenia ($-1.0 > T > -2.5$), Osteoporosis ($T \le -2.5$), or Severe Osteoporosis ($T \le -2.5$ plus fragility fracture). Primary osteoporosis is divided into Type I (postmenopausal, estrogen withdrawal, rapid trabecular loss) and Type II (senile, cortical and trabecular thinning, osteoblast senescence, impaired calcium absorption).

Defining Osteoporosis: Bone Strength, Density, and Quality

The National Institutes of Health (NIH) and the World Health Organization (WHO) define osteoporosis as a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and fracture susceptibility. For densitometry technologists, understanding that bone strength depends on both density and material quality is fundamental:

$\text{Bone Strength} = \text{Bone Mineral Density (BMD)} + \text{Bone Quality}$

• Bone Mineral Density (BMD): Quantified by dual-energy X-ray absorptiometry (DXA) in grams of mineral per square centimeter of projected area ($\text{g/cm}^2$). In mechanical testing, areal BMD accounts for approximately 60% to 70% of ultimate skeletal breaking strength.
• Bone Quality: Encompasses architectural and material properties not captured by 2D DXA: trabecular microarchitecture (connectivity and plate-to-rod transitions), cortical geometry and porosity, collagen cross-linking (enzymatic pyridinoline vs. non-enzymatic glycation products), mineralization degree, and accumulated microdamage.

Primary Osteoporosis: Type I vs. Type II Pathophysiology

Primary osteoporosis occurs without an underlying systemic medical disorder. Albright, and later Riggs and Melton, classified primary osteoporosis into Type I (postmenopausal) and Type II (senile or age-related):

Type I Osteoporosis (Postmenopausal)

• Epidemiology: Manifests in women aged 50 to 70 within 15 to 20 years after menopause (female-to-male ratio ~6:1).
• Etiology: Acute estrogen withdrawal. Estrogen suppresses bone resorption by limiting pro-inflammatory cytokines (IL-1, IL-6, TNF-α) and maintaining osteoprotegerin (OPG). Estrogen deficiency surges RANKL, driving osteoclast proliferation, activation, and survival.
• Remodeling Dynamics: Acute high-turnover state where osteoclastic resorption outpaces osteoblast formation.
• Compartmental Loss: Selective, rapid loss of trabecular bone (3% to 5% annually in early postmenopause), causing trabecular thinning and horizontal plate perforation.
• Fracture Profile: Vertebral crush/wedge fractures and distal forearm (Colles') fractures.

Type II Osteoporosis (Senile / Age-Related)

• Epidemiology: Manifests in elderly men and women aged 70 and older (female-to-male ratio ~2:1).
• Etiology: Cellular senescence and multi-organ endocrine aging:
  1. Osteoblast Senescence: Mesenchymal stem cells shift toward adipogenesis; osteoblasts exhibit blunted replication and matrix synthesis.
  2. Impaired Calcium-PTH Axis: Declining renal 1-alpha-hydroxylase reduces calcitriol [$1,25(\text{OH})_2\text{D}$] synthesis. Impaired intestinal calcium absorption triggers secondary hyperparathyroidism, persistently elevating parathyroid hormone (PTH) to resorb skeletal calcium.
  3. Sex Steroid Deficiency: Gradual loss of estrogens and androgens in aging individuals.
• Compartmental Loss: Slow, steady bone loss (~0.5% to 1% annually) affecting both cortical and trabecular compartments proportionately, with cortical thinning and Haversian canal porosity.
• Fracture Profile: Hip fractures (femoral neck and intertrochanteric), pelvis, proximal humerus, and multiple vertebral wedge fractures causing thoracic kyphosis ("dowager's hump").

Secondary Osteoporosis Overview

Secondary osteoporosis refers to bone loss resulting from an identifiable systemic medical condition, endocrine pathology, malabsorption disorder, or medication regimen. Secondary causes occur in up to 30% of postmenopausal women and over 50% of men presenting with osteoporosis. Key etiologies—such as hyperparathyroidism, celiac disease, and systemic glucocorticoid therapy—are detailed in Section 1.3.

WHO Diagnostic Criteria Based on T-Score

The World Health Organization (WHO) established diagnostic criteria for postmenopausal women and men aged 50 and older using central DXA (lumbar spine, proximal femur, or forearm). The T-score reflects the standard deviations (SD) a patient's BMD deviates from the mean of a healthy young-adult reference population (aged 20–29, using the NHANES III female reference database for the hip):

$\text{T-score} = \frac{\text{Patient BMD} - \text{Young-Adult Mean BMD}}{\text{Young-Adult Standard Deviation}}$

Each 1.0 SD decrease in T-score roughly doubles to triples relative fracture risk.

Fragility Fractures: Definition and Diagnostic Rules

A fragility fracture (low-trauma fracture) is clinically defined as a fracture sustained from mechanical forces that would not fracture healthy bone—specifically, trauma resulting from a fall from a standing height or less, or occurring during routine daily activities without external trauma (e.g., coughing, turning, or lifting light objects).

• Major Osteoporotic Fracture (MOF) Sites: The four hallmark sites tracked in clinical risk models (e.g., FRAX) are: 1) Vertebrae (clinical or morphometric compression), 2) Hip (femoral neck, intertrochanteric, subtrochanteric), 3) Distal forearm (distal radius / Colles' fracture), and 4) Proximal humerus.
• Anatomical Exclusions: Fractures of the skull, facial bones, cervical spine, hands, metacarpals, feet, and metatarsals are explicitly excluded from the definition of osteoporotic fragility fractures because they typically reflect high-energy trauma, local stress, or distinct biomechanical forces rather than generalized skeletal fragility.
• The Imminent Fracture Cascade: An initial fragility fracture doubles to quadruples future fracture risk, with up to 50% of secondary fractures occurring within the first 12 to 24 months (imminent fracture risk).